论文部分内容阅读
目的:了解分化型甲状腺癌RAI治疗患者的自我管理效能水平,并分析其影响因素。方法:采用中文版SUPHH问卷、医学应对问卷、医院焦虑抑郁量表和患者一般情况问卷对363例分化型甲状腺癌RAI治疗患者进行问卷调查。结果:分化型甲状腺癌RAI治疗患者自我管理效能感得分为(89.71±19.45)分;多元线性回归结果显示,抑郁、面对、回避、屈服、性格、病理分期、知情是自我管理效能感的主要影响因素。结论:分化型甲状腺癌RAI治疗患者自我管理效能感处于中等水平,有待提高;临床医护人员可参考影响患者自我管理效能感因素,有针对性地帮助患者制定疾病自我管理方案,从而提升患者的生存质量。
Objective: To understand the self-management efficacy of patients with differentiated thyroid cancer treated with RAI and analyze its influencing factors. Methods: A total of 363 patients with differentiated thyroid cancer were enrolled in the questionnaire survey using the Chinese version of the SUPHH questionnaire, the medical coping questionnaire, the hospital anxiety and depression scale, and the general questionnaire of patients. Results: The score of self-management efficacy in patients with differentiated thyroid cancer treated with RAI was (89.71 ± 19.45) points. Multivariate linear regression analysis showed that depression, confrontation, avoidance, surrender, personality and pathological staging were the main self-management efficacy Influencing factors. Conclusion: Patients with differentiated thyroid cancer RAI treatment self-efficacy is at a moderate level, to be improved; clinical staff can refer to the self-efficacy of patients with self-management factors, targeted to help patients develop self-management programs to improve patient survival quality.